COSCIENS Biopharma Inc.

NASDAQ: CSCI · Real-Time Price · USD
2.69
-0.20 (-6.92%)
At close: Aug 19, 2025, 3:59 PM
2.61
-2.79%
Pre-market: Aug 20, 2025, 08:00 AM EDT

COSCIENS Biopharma Revenue

COSCIENS Biopharma reported an annual revenue of $9.13M, reflecting a 27.77% growth. For the quarter ending March 31, 2025, COSCIENS Biopharma generated $1.5M in revenue.
Revenue (ttm)
9.13M
Revenue Growth
27.77%
Price / Sales Ratio
0.78
Revenue / Employee
228.17K
Employees
40
Market Cap
8.45M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 9.13M +27.77%
Dec 31, 2023 7.14M -50.98%
Dec 31, 2022 14.57M +8.05%
Dec 31, 2021 13.49M +13.73%
Dec 31, 2020 11.86M +20.27%
Dec 31, 2019 9.86M +15.85%
Dec 31, 2018 8.51M -17.20%
Dec 31, 2017 10.28M +1.04%
Dec 31, 2016 10.17M +32.34%
Dec 31, 2015 7.69M +0.38%
Dec 31, 2014 7.66M +24.99%
Dec 31, 2013 6.13M +18.01%
Dec 31, 2012 5.19M -8.38%
Dec 31, 2011 5.67M +1.64%
Dec 31, 2010 5.58M +33.60%
Dec 31, 2009 4.17M +20.13%
Dec 31, 2008 3.47M -0.21%
Dec 31, 2007 3.48M +22.59%
Dec 31, 2006 2.84M +22.92%
Dec 31, 2005 2.31M +41.93%
Dec 31, 2004 1.63M -4.84%
Dec 31, 2003 1.71M +81.08%
Dec 31, 2002 944.66K +30.84%
Dec 31, 2001 722.02K +33.85%
Dec 31, 2000 539.41K +139.37%
Dec 31, 1999 225.34K -13.32%
Dec 31, 1998 259.96K -83.83%
Dec 31, 1997 1.61M +267.10%
Dec 31, 1996 437.83K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.